Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0263083 ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES
The invention provides compounds of formula Ia, Ib and Ic: ##STR00001## and salts thereof, wherein variables are as described in the specification, as well as...
2016/0263082 Method For Treating Nicotine Withdrawal Symptoms
The present invention relates to a method for treating symptoms from a nicotine withdrawal comprising administering to a patient an effective amount of a...
2016/0263081 ANTIPARASITIC AGENT
Provided is a new antiparasitic agent for medical use, veterinary use, agrochemical use, and use in fish, said antiparasitic agent having an effect on both...
2016/0263080 LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC...
Compounds, methods, and compositions are provided for the treatment of cancer, neurological disorders, and fibrotic disorders. Specifically, the invention...
2016/0263079 SIRT 1 ACTIVATOR INCLUDING SYRINGARESINOL
The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically...
2016/0263078 SIRT 1 ACTIVATOR INCLUDING SYRINGARESINOL
The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically...
2016/0263077 SIRT 1 ACTIVATOR INCLUDING SYRINGARESINOL
The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically...
2016/0263076 MEDICAL DEVICE RAPID DRUG RELEASING COATINGS COMPRISING OILS, FATTY ACIDS AND/OR LIPIDS
The invention relates to a coated medical device for rapid delivery of a therapeutic agent to a tissue in seconds to minutes. The medical device has a layer...
2016/0263075 FERRIC CITRATE DOSAGE FORMS
The disclosre relates to ferric citrate tablets and dosage forms.
2016/0263074 METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG
A metal-salen complex compound, which exhibits excellent noninvasiveness and can be efficiently transferred to an affected site, a local anesthetic containing...
2016/0263073 MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION HAVING A MECHANICAL BASIS
Compositions comprising monoacylglycerols (MAG), such as sn-1(3) MAG, are administered to an individual having or at risk of malabsorption having a mechanical...
2016/0263072 MONOACYLGLYCEROLS AND FAT-SOLUBLE NUTRIENTS FOR USE IN THE TREATMENT OF MALABSORPTION HAVING A NON-MECHANICAL BASIS
Compositions comprising monoacylglycerols (MAG), such as sn-1(3) MAG, and further comprising fat-soluble nutrients, such as fat-soluble vitamins and...
2016/0263071 NEURODEGENERATIVE DISORDERS AND METHODS OF TREATMENT AND DIAGNOSIS THEREOF
This invention relates to compositions and methods for the therapy and diagnosis of neurodegenerative or neuromuscular disorders. More particularly, this...
2016/0263070 Therapeutic Compositions
Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
2016/0263069 Therapeutic Compositions
Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
2016/0263068 Therapeutic Compositions
Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
2016/0263067 Therapeutic Compositions
Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
2016/0263066 ISOTOPICALLY MODIFIED COMPOUNDS AND THEIR USE AS FOOD SUPPLEMENTS
A nutrient composition comprises an essential nutrient in which at least one exchangeable H atom is .sup.2H and/or at least one C atom is .sup.13C. The...
2016/0263065 TOPICAL PHARMACEUTICAL GEL COMPOSITION OF DICLOFENAC SODIUM
A topical pharmaceutical gel composition of diclofenac sodium suitable for twice daily application is provided. The topical gel composition contains at least...
2016/0263064 COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION
Compositions for the treatment of shock, autodigestion, multi-organ failure, intestinal ischemia, or intestinal hypoperfusion are provided.
2016/0263063 LIQUID DOSAGE FORMS OF SODIUM NAPROXEN
Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the...
2016/0263062 ANTIMICROBIAL COMPOSITIONS
Antimicrobial compositions and related methods are disclosed. The antimicrobial compositions include glycolic acid, an anionic surfactant, and at least one...
2016/0263061 DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the...
2016/0263060 AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
The invention provides the use of compound of formula V or formula VI in the treatment of a demyelinating peripheral neuropathy: ##STR00001## wherein X, R.sub.1,...
2016/0263059 EPINEPHRINE FORMULATIONS
Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an...
2016/0263058 COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the...
2016/0263057 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0263056 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0263055 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0263054 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0263053 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0263052 COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the...
2016/0263051 STABLE LIQUID FORMULATIONS OF VOLATILE GAS ANESTHETICS
A stable liquid nanoemulsion of a volatile gas anesthetic, such as, isoflurane or sevoflurane, is disclosed which is effective in inducing and maintaining a...
2016/0263050 METHOD FOR INDUCING DEATH OF A CANCER CELL
The present invention provides a method for inducing death of a cancer cell in a subject in need thereof comprising administering to the subject a...
2016/0263049 KIT CONTAINING PATCHES AND COMPOSITION FOR INSECT BITE TREATMENT
A kit for treating insect bites includes a plurality of patches of different size and shape, and a container of a composition containing extracts of garlic and...
2016/0263048 BIOADHESIVE POLYMER-BASED CONTROLLED-RELEASE SYSTEMS, PRODUCTION PROCESS AND CLINICAL USES THEREOF
The invention relates to release systems based on bioadhesive polymers, their manufacturing process and to their uses in the medical, pharmaceutical, cosmetic,...
2016/0263047 Nanoparticle Compositions and Methods as Carriers of Nutraceutical Factors Across Cell Membranes and Biological...
Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.
2016/0263046 VORTEX-INDUCED SILK FIBROIN GELATION FOR ENCAPSULATION AND DELIVERY
The present invention provided for a novel process of forming silk fibroin gels, and controlling the rate of .beta.-sheet formation and resulting hydrogelation...
2016/0263045 Floating Gastric Retentive Dosage Form
An elongate dosage form of generally cylindrical shape having two opposing ends, the dosage form being buoyant in gastric fluid, wherein the dosage form is...
2016/0263044 METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM
A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
2016/0263043 Controlled Release Dosage Form
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABA.sub.B receptor agonist contained in...
2016/0263042 OSMOTIC DRUG DELIVERY SYSTEM
An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in...
2016/0263041 METHOD FOR MANUFACTURING A COMPOUND DANSHEN DRIPPING PILL
A method for manufacturing a compound danshen dripping pill is disclosed. The method comprises: mixing powders of active substances with an excipient in a...
2016/0263040 COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINE
A composite formulation is provided which includes: tadalafil or a pharmaceutically acceptable salt thereof as an active ingredient; and amlodipine or a...
2016/0263039 TABLET
A tablet is provided that has a shape parameter that may securely inhibit defects in a manufacturing procedure in an actual production scale based on an...
2016/0263038 TABLET CONTAINING FERRIC CITRATE
The present invention provides a new preparation which is a tablet containing (1) ferric citrate, (2) a polyvinyl alcohol-polyethylene glycol graft copolymer,...
2016/0263037 ABUSE-PROOFED DOSAGE FORM
The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural...
2016/0263036 Highly Compactable and Durable Direct Compression Excipients and Excipient Systems
The present invention relates to solid dispersions including, but not limited to, co-processed carbohydrates with different solubilities and concentrations,...
2016/0263035 SUSTAINED RELEASE FORMULATION OF NALBUPHINE
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine...
2016/0263034 MANUFACTURE OF A PHARMACEUTICAL PRODUCT
The invention concerns an emulsion-based method for the manufacture of a crystalized spherical agglomerate and/or a pharmaceutical product; and crystalized...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.